Trial Profile
Oral Administration of the GnRH Antagonist Acyline in Normal Men Part II: Multiple-dose Pharmacokinetics (Acyline-7/MER 104-02).
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Acyline (Primary)
- Indications Prostate cancer
- Focus Pharmacokinetics
- 21 Sep 2008 Actual end date (February 2008) added as reported by ClinicalTrials.gov.
- 21 Sep 2008 Actual start date changed from February 2008 to January 2008 as reported by Clinicaltrials.gov
- 21 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.